Clinical Trial Update: A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003 [Phase 1]

View source ↗

Summary

This phase 1 trial update notes the completion of a single- and multiple-ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• CAT-2003

Snippet

Sponsor: Catabasis Pharmaceuticals | Conditions: Dyslipidemia | Phase 1 | Status: COMPLETED